YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer
Article in Cancer Letters (August 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Cancer Letters (August 2024)
Article in Journal of Molecular Pathology (February 2024)
Article in Translational Cancer Research (January 2024)